Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, learn about the importance of utilising biomarkers within clinical trials and how to go about developing effective biomarker strategies. Attendees will learn how to implement an effective structure for developing clinically relevant biomarker strategies and enhance the success rate of clinical trials. The featured speakers will discuss the value of machine-learning for disease stratification and how it can significantly improve the prediction of treatment response and drug efficacy.

The real value of biomarker insights have not been fully realized due the limitations in the development and implementation of effective biomarker strategies in many clinical programmes across therapeutic areas, resulting in the absence of predictive biomarkers in the latest drug approvals.

Biomarker quantification plays an integral role in the drug development process, providing guidance for downstream decision-making that has shown to correlate positively with clinical trial success. Biomarker-based stratification enriches clinical populations, reducing cost and trial duration. However, the real value of biomarker insights have not been fully realized due the limitations in the development and implementation of effective biomarker strategies in many clinical programmes across therapeutic areas, resulting in the absence of predictive biomarkers in the latest drug approvals.

It is also worth considering the prospect of applying machine-learning to biomarker assessment, which promises improved patient stratification of treatment response to drive drug development.

Register to learn about the importance of utilising biomarkers within clinical trials and how to go about developing effective biomarker strategies.

Join experts from Synexa Life Sciences, Justin Devine, CMO & Interim CSO; and Nicholas Woudberg, Scientific Engagement and Proposals Manager, for the live webinar on Friday, November 18, 2022, at 10am EST (4pm CET/EU-Central).

For more information, or to register for this event, visit Clinically-Relevant Biomarker Strategies in Drug Development and the Potential of Machine-Learning for Biomarker Assessment.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Vera Kovacevic
Xtalks
+1 (416) 977-6555 x371
Email >
Visit website